Explained – Why this Smallcap Pharma stock jumped 13% for its best day in two years

Orchid’s partnership with Pharmasyntez marks an important step in making Exblifep available to patients in Russia, according to Orchid Pharma Managing Director Manish Dhanuka.

Leave a Reply

Your email address will not be published. Required fields are marked *